The increasing field of immunotherapy relies heavily on recombinant mediator technology, and a thorough understanding of individual profiles is paramount for refining experimental design and therapeutic efficacy. https://companyspage.com/story5933781/understanding-recombinant-cytokine-profiles-il-1a-il-1b-il-2-and-il-3